Insulin pumps, which deliver fast-acting insulin continuously through a catheter and are often preferred over injections, are still only used by only 20 to 30 percent of the 1.5 million people in the U.S. who are diagnosed with Type I diabetes.
Pumps might start getting more popular as the systems are get smaller, sleeker, and easier to use. Take Tandem Diabetes Care's t:slim, an insulin delivery system that has just been cleared by the FDA.
It's not only the smallest, but also the first to employ touch screen technology. Friends just might get gadget envy.… Read more